Industry 4.0 Technology-based Diagnosis for COVID-19

Abstract

The surveillance of the 2019 coronavirus disease (COVID-19) is enormous on the world’s list of concerns associated with the rapid expansion of the virus. Global results indicate that, among more than 1.6 million confirmed cases, the percentage of people infected with COVID-19 is dramatically increasing; the disease has significantly overwhelmed and limited the performance of health systems in the world. Both individuals and organizations have faced unprecedented resource depletion in such things as personal protective equipment (PPE) and other manufactured devices, such as gloves, face masks, sunglasses and guards, and oxygen nozzles for cardiovascular machinery. Industry 4.0, the Internet of Things (IoT), cyber-physical systems (CPS), information and communication technology (ICT), enterprise architecture (EA), and enterprise integration (EI), artificial intelligence (AI), and biosensors have attracted a lot of attention and are closely linked. The goal of Industry 4.0 is to develop a new generation of effectiveness and profitability of operations and, perhaps, a higher degree of automation. Digitalization, standardization, and customizability of the production process are among the significant features of Industry 4.0, along with integration and mitigation, human machine interaction (HMI), valuation services and companies, and highly autonomous synchronization. Oftentimes, these attributes are positively linked to internet systems and innovative algorithms, but they also signify that Industry 4.0 is a process of knowledge management. Vigorous community widening of the radically new human coronavirus 2019 (nCOVID-19 or SARS-Cov-2) and mortality statistics have given rise to an incomparable urge for definitive evaluation of specific and precise detection followed by contact tracing and containment strategies, especially when no vaccine or pharmacogenomics are widely acknowledged. To address this entirely new multinational outbreak of disease, the World Health Organization (WHO), research doctors, and healthcare professionals are seeking innovations to evaluate infected individuals at various stages, to select the ideal medical test, to combat the effects of this virus, to develop immunization for the treatment of infected individuals, and to monitor reinfected patients. Recent studies have shown that technology based on Industry 4.0 is a versatile platform used in medical health tasks by various healthcare providers as it results in improvements in scale-up, speeded-up power consumption, consistency, and even human performance. Therefore, a range of fourth industrial techniques have been described by healthcare systems and offshore specialists to exploit the resources to address the COVID-19 outbreak. This study sets out to evaluate the impact of the practices described on the management of COVID-19.